Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study January 1, 2022 J Clin Aesthet Dermatol. 2022;15(1):53–58. by Ulrich Mrowietz, MD; Leon Kircik, MD; CONTINUE READING »
